Mvasi Injection, Solution
Product Images NDC 55513-207
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Mvasi (NDC 55513-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amgen, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Mvasi 02)
Figure 3 (Mvasi 03)
Figure 4 (Mvasi 04)
Figure 5 (Mvasi 05)
Figure 6 (Mvasi 06)
Figure 7 (Mvasi 07)
Figure 8 (Mvasi 08)
Figure 9 (Mvasi 09)
Principal Display Panel 100 mg/4 mL Mvasi™ (bevacizumab-awwb) Injection Ndc 55513-206-01 Single Dose Vial Discard Unused Portion 100 mg/4 mL (25 mg/ml) Contains 1 Single Dose Vial For Intravenous Infusion After Dilution Store Refrigerated At 2°c To 8°c (36°f To 46°f). Protect From Light. Do Not Freeze Or Shake Sterile Solution – No Preservative Rx Only Amgen® (Mvasi 10)
Principal Display Panel 400 mg/16 mL Mvasi™ (bevacizumab-awwb) Injection Ndc 55513-207-01 Single Dose Vial Discard Unused Portion 400 mg/16 mL (25 mg/ml) Contains 1 Single Dose Vial For Intravenous Infusion After Dilution Store Refrigerated At 2°c To 8°c (36°f To 46°f). Protect From Light. Do Not Freeze Or Shake Sterile Solution – No Preservative Rx Only Amgen® (Mvasi 11)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.